|
RVX ANNOUNCES DOSING OF FIRST TWO PATIENTS IN EXPANDED RENAL AND ORPHAN PROGRAMS
|
3
|
Resverlogix Corp.
|
Jul 21, 2016 02:38PM
|
|
Re: OVERALL AN EXCELLENT PRESENTATION AT R AND R TODAY SEPT 10, 2015
|
3
|
Resverlogix Corp.
|
Sep 10, 2015 11:11AM
|
|
Resverlogix Announces Change to its Board of Directors
|
3
|
Resverlogix Corp.
|
Dec 11, 2019 08:37AM
|
|
Re: From gv on SH
|
3
|
Resverlogix Corp.
|
Jan 04, 2016 03:39PM
|
|
Re: ZEN003694 Trial is now recruiting patients
|
3
|
Zenith Epigenetics
|
May 03, 2016 10:53AM
|
|
Re: Buyout?......
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 07:50AM
|
|
Re: RVX ANNOUNCES DOSING OF FIRST TWO PATIENTS IN EXPANDED RENAL AND ORPHAN PROGRAMS
|
3
|
Resverlogix Corp.
|
Jul 21, 2016 02:42PM
|
|
Re: Its out on SEDAR...
|
3
|
Resverlogix Corp.
|
Nov 15, 2016 02:50PM
|
|
Re: Statistical Considerations
|
3
|
Resverlogix Corp.
|
Mar 09, 2018 11:58AM
|
|
If Constellation can do it........
|
3
|
Zenith Epigenetics
|
Apr 13, 2018 08:29AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
3
|
Resverlogix Corp.
|
Aug 04, 2020 10:47AM
|
|
Re: Dr. Mark Day interview with Proactive Investors at BIO CEO
|
3
|
BIOASIS TECHNOLOGIES INC
|
Feb 13, 2019 02:09PM
|
|
Re: AACR 2019
|
3
|
Zenith Epigenetics
|
Feb 28, 2019 01:48PM
|
|
Re: ERA-EDTA 2019 June 13-16
|
3
|
Resverlogix Corp.
|
Jun 12, 2019 07:57PM
|
|
PROMINENT
|
3
|
Resverlogix Corp.
|
Nov 10, 2017 05:02PM
|
|
Re: AHA BETonMACE Slides are up
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 04:35PM
|
|
Re: Biogen getting hammered
|
3
|
Resverlogix Corp.
|
Dec 04, 2019 03:01PM
|
|
Re: News on Amgen's collesteral drug, Repatha; poor sales / resistant payer uptake
|
3
|
Resverlogix Corp.
|
Apr 27, 2017 12:50PM
|
|
Biotech Showcase, Jan 13-15
|
3
|
Resverlogix Corp.
|
Dec 13, 2019 09:07AM
|
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Apr 13, 2018 09:23AM
|
